(Q36445471)

14 August 2017

1 reference

title

Valproate as a mainstay of therapy for pediatric epilepsy (English)

1 reference

14 August 2017

Renzo Guerrini

1

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

113-129

1 reference

https://scigraph.springernature.com/pub.10.2165/00148581-200608020-00004

14 August 2017

exact match

0 references

cites work

Cognitive side effects of antiepileptic drugs in children

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Disposition of sodium valproate in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Pharmacokinetics and bioavailability of sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Clinical valproate toxicity induced by acetylsalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Effect of L-carnitine treatment for valproate-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Gastrointestinal tolerance of divalproex sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Valproic acid versus ethosuximide in the treatment of absence seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Use of Valproic Acid in Treatment of Infantile Spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Exacerbation of juvenile myoclonic epilepsy with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200608020-00004

Electrophysiological characterization of spontaneous and carbamazepine-induced epileptic negative myoclonus in benign childhood epilepsy with centro-temporal spikes

21 January 2018

1 reference

12 December 2020

Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis

1 reference

12 December 2020

A risk-benefit assessment of therapies for Lennox-Gastaut syndrome

1 reference

12 December 2020

Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)

1 reference

12 December 2020

Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood.

1 reference

12 December 2020

Acquired epileptiform aphasia in children (Landau-Kleffner syndrome).

1 reference

12 December 2020

l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives

1 reference

12 December 2020

Infantile spasms treated with high doses of sodium valproate: initial response and follow-up

1 reference

12 December 2020

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience

1 reference

12 December 2020

Pathophysiology of myoclonic epilepsies.

1 reference

12 December 2020

Valproic acid treatment of learning disorder and severely epileptiform EEG without clinical seizures.

1 reference

12 December 2020

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

1 reference

12 December 2020

Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment

1 reference

12 December 2020

Landau-Kleffner Syndrome: A Pharmacologic Study of Five Cases

1 reference

12 December 2020

Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy

1 reference

12 December 2020

Idiopathic photosensitive occipital lobe epilepsy

1 reference

12 December 2020

Valproate-associated pancreatitis

1 reference

12 December 2020

Prevention of recurrent febrile convulsions--a randomized therapeutic assay: sodium valproate, phenobarbital and placebo

1 reference

12 December 2020

Cognitive Impairment in New Cases of Epilepsy Randomly Assigned to Carbamazepine, Phenytoin and Sodium Valproate

1 reference

12 December 2020

Sodium valproate: monotherapy and polytherapy

1 reference

12 December 2020

The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin

1 reference

12 December 2020

Altered cognitive functioning in children with idiopathic epilepsy receiving valproate monotherapy

1 reference

12 December 2020

On the association between valproate and polycystic ovary syndrome

1 reference

12 December 2020

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

1 reference

12 December 2020

Methsuximide for intractable childhood seizures

1 reference

12 December 2020

Urinary excretion of valproate and some metabolites in chronically treated patients

1 reference

12 December 2020

Valproate-associated pancreatitis and cholecystitis in six mentally retarded adults

1 reference

12 December 2020

Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment

1 reference

12 December 2020

A meta-analytic review of the preventive treatment of recurrences of febrile seizures

1 reference

12 December 2020

Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity

1 reference

12 December 2020

Tonic Status Epilepticus precipitated by Intravenous Benzodiazepine in Five Patients with Lennox-Gastaut Syndrome

1 reference

12 December 2020

Visual sensitivity and epilepsy: a proposed terminology and classification for clinical and EEG phenomenology

1 reference

12 December 2020

Rationale for treating epilepsy in children.

1 reference

12 December 2020

Sodium valproate versus phenobarbital in the prophylactic treatment of febrile convulsions in childhood.

1 reference

12 December 2020

Pharmacokinetics of total and free valproic acid during monotherapy in infants

1 reference

12 December 2020

1 reference

12 December 2020

Valproic acid and thrombocytopenia in children: a case-controlled retrospective study

1 reference

12 December 2020

Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the Study of Epilepsy

1 reference

12 December 2020

Cortical myoclonus in Angelman syndrome

1 reference

12 December 2020

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

1 reference

12 December 2020

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

1 reference

12 December 2020

A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group

1 reference

12 December 2020

Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study

1 reference

12 December 2020

Antiepileptic drug-induced worsening of seizures in children

1 reference

12 December 2020

Valproic acid in the treatment of intractable absence seizures in children: a single-blind clinical and quantitative EEG study

1 reference

12 December 2020

Successful prophylaxis against febrile convulsions with valproic acid or phenobarbitone

1 reference

12 December 2020

Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents

1 reference

12 December 2020

Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2.

1 reference

12 December 2020

[Epilepsy with continuous discharges during slow-wave sleep. Treatment with clobazam].

1 reference

12 December 2020

Valproate-induced epileptic tonic status

1 reference

12 December 2020

Hematologic toxicity of sodium valproate

1 reference

12 December 2020

On the toxicity of valproic-acid.

1 reference

12 December 2020

Randomised controlled trials of phenobarbitone and valproate in febrile convulsions

1 reference

12 December 2020

Landau-Kleffner syndrome: epileptic activity in the auditory cortex

1 reference

12 December 2020

The management of refractory idiopathic epilepsies

1 reference

12 December 2020

Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders

1 reference

12 December 2020

Benign myoclonic epilepsy in infants: video-EEG features and long-term follow-up.

1 reference

12 December 2020

Intravenous valproate dosing in neonates

1 reference

12 December 2020

Continuous spikes and waves during slow sleep: a 30 months follow-up study of neuropsychological recovery and EEG findings.

1 reference

12 December 2020

Treatment of Infantile Spasms with Sodium Dipropylacetic Acid

1 reference

12 December 2020

Serum and hair zinc levels in epileptic children taking valproic acid

1 reference

12 December 2020

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

1 reference

12 December 2020

Cortical dysplasias, genetics, and epileptogenesis.

1 reference

12 December 2020

Familial cortical myoclonic tremor as a unique form of cortical reflex myoclonus.

1 reference

12 December 2020

Semiology of typical and atypical Rolandic epilepsy: a video-EEG analysis.

1 reference

12 December 2020

Hair loss in psychopharmacology

1 reference

12 December 2020

Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs

1 reference

12 December 2020

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

1 reference

12 December 2020

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents

1 reference

12 December 2020

Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain

1 reference

12 December 2020

Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.

1 reference

12 December 2020

Drug interactions with valproic acid

1 reference

12 December 2020

Therapy of infantile spasms with valproate: results of a prospective study

1 reference

12 December 2020

Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.

1 reference

12 December 2020

The spectrum of acquired cognitive disturbances in children with partial epilepsy and continuous spike-waves during sleep. A 4-year follow-up case study with prolonged reversible learning arrest and dysfluency.

1 reference

12 December 2020

Effect of Early Corticosteroid Therapy for Landau-Kleffner Syndrome

1 reference

12 December 2020

A follow-up survey on seizures induced by animated cartoon TV program "Pocket Monster"

1 reference

12 December 2020

Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration

1 reference

12 December 2020

Effectiveness and toxicity of phenobarbital, primidone, and sodium valproate in the prevention of febrile convulsions, controlled by plasma levels

1 reference

12 December 2020

Weight gain during treatment with valproate

1 reference

12 December 2020

Electrical status epilepticus in childhood: neuropsychological impairment and therapeutic management.

1 reference

12 December 2020

Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence

1 reference

12 December 2020

Clinical pharmacokinetics of valproic acid--1988.

1 reference

12 December 2020

Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes.

1 reference

12 December 2020

Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications

1 reference

12 December 2020

Valproate sodium: a controlled clinical trial including monitoring of drug levels

1 reference

12 December 2020

Epileptic syndromes and visually induced seizures

1 reference

12 December 2020

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

1 reference

12 December 2020

Treatment of photosensitivity.

1 reference

12 December 2020

Abnormal corticomuscular and intermuscular coupling in high-frequency rhythmic myoclonus.

1 reference

12 December 2020

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action

1 reference

12 December 2020

First-dose and steady-state pharmacokinetics of valproic acid in children with seizures

1 reference

12 December 2020

The effect of valproic acid on blood loss in patients with cerebral palsy

1 reference

12 December 2020

Tolerability of oral loading of divalproex sodium in child psychiatry inpatients

1 reference

12 December 2020

Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications

1 reference

12 December 2020

Seizure types and syndromes: lumping or splitting

1 reference

12 December 2020

The myoclonic epilepsies of childhood

1 reference

12 December 2020

Epilepsy with continuous spike-waves during slow sleep and its treatment.

1 reference

12 December 2020

Acute intoxication with valproate

1 reference

12 December 2020

Treatment of myoclonic epilepsies of childhood, adolescence, and adulthood

1 reference

12 December 2020

Sodium valproate monotherapy in childhood epilepsy.

1 reference

12 December 2020

Alertness and incidence of seizures in patients with Lennox-Gastaut syndrome.

1 reference

12 December 2020

The epidemiology of the epilepsies in children

1 reference

12 December 2020

Platelet count and function in children receiving sodium valproate

1 reference

12 December 2020

[Acquired aphasia in epileptic children--four cases with electrical infraclinic status epilepticus during sleep (author's transl)]

1 reference

12 December 2020

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

1 reference

12 December 2020

10.2165/00148581-200608020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1025121987

0 references

Fatcat ID

release_2z36naimtzgt5l6si7kef6qch4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2z36naimtzgt5l6si7kef6qch4

24 November 2022

mapped directly with Wikidata item

1 reference